Related Experiment Video
Updated: May 19, 2026
07:51
Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling
Published on: March 20, 2026
Targeting tetraspanins in cancer
Mónica Sala-Valdés1, Naouel Ailane, Céline Greco
1André Lwoff Institute, Inserm U1004, Hôpital Paul Brousse, 14 Avenue Paul Vaillant Couturier, Villejuif 94800, France. monica.sala-valdes@inserm.fr
Expert Opinion on Therapeutic Targets
|August 14, 2012
Summary
Targeting tetraspanins, proteins forming cellular networks, shows promise for cancer therapy. These proteins are crucial in tumor formation, growth, and metastasis, making them a potential therapeutic target.
Area of Science:
- Molecular Biology
- Cellular Biology
- Oncology
Background:
- Tetraspanins are transmembrane proteins that form complexes, creating tetraspanin-enriched microdomains (TEMs).
- These TEMs act as signaling platforms involved in critical cellular functions and cancer development.
Purpose of the Study:
- This review explores the therapeutic strategies for targeting tetraspanins in cancer treatment.
- It examines the rationale behind using tetraspanins as a therapeutic target in oncology.
Main Methods:
- The review synthesizes existing research on tetraspanin function in cancer.
- It discusses various methods and approaches for targeting tetraspanin complexes.
Main Results:
- Tetraspanins play significant roles in multiple stages of tumorigenesis.
- Their involvement spans tumor cell communication, dissemination, and the formation of metastases.
Conclusions:
- Targeting tetraspanins represents a promising therapeutic avenue for cancer treatment.
- Their critical roles in tumor progression suggest potential for novel anti-cancer strategies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...